316 related articles for article (PubMed ID: 7905449)
1. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma.
Nakamori S; Ota DM; Cleary KR; Shirotani K; Irimura T
Gastroenterology; 1994 Feb; 106(2):353-61. PubMed ID: 7905449
[TBL] [Abstract][Full Text] [Related]
2. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction.
Noguchi S; Aihara T; Nakamori S; Motomura K; Inaji H; Imaoka S; Koyama H
Cancer; 1994 Sep; 74(5):1595-600. PubMed ID: 7520351
[TBL] [Abstract][Full Text] [Related]
3. Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody.
Baeckström D; Nilsson O; Price MR; Lindholm L; Hansson GC
Cancer Res; 1993 Feb; 53(4):755-61. PubMed ID: 7679050
[TBL] [Abstract][Full Text] [Related]
4. Significance of MUC1 and MUC2 mucin expression in colorectal cancer.
Ajioka Y; Allison LJ; Jass JR
J Clin Pathol; 1996 Jul; 49(7):560-4. PubMed ID: 8813954
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma.
Matsuda K; Masaki T; Watanabe T; Kitayama J; Nagawa H; Muto T; Ajioka Y
Jpn J Clin Oncol; 2000 Feb; 30(2):89-94. PubMed ID: 10768872
[TBL] [Abstract][Full Text] [Related]
6. [Expression of mucin MUC1 and MUC2 in colorectal carcinoma and their clinical significance].
Huang WB; Shi LH; Zhu XQ; Xu GX; Qi Q
Ai Zheng; 2002 Nov; 21(11):1231-4. PubMed ID: 12526222
[TBL] [Abstract][Full Text] [Related]
7. Mucin expression by transitional cell carcinomas of the bladder.
Walsh MD; Hohn BG; Thong W; Devine PL; Gardiner RA; Samaratunga ML; McGuckin MA
Br J Urol; 1994 Mar; 73(3):256-62. PubMed ID: 8162502
[TBL] [Abstract][Full Text] [Related]
8. Expression of sulfomucins in normal mucosae, colorectal adenocarcinomas, and metastases.
Matsushita Y; Yamamoto N; Shirahama H; Tanaka S; Yonezawa S; Yamori T; Irimura T; Sato E
Jpn J Cancer Res; 1995 Nov; 86(11):1060-7. PubMed ID: 8567397
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues.
Guo Q; Tang W; Inagaki Y; Midorikawa Y; Kokudo N; Sugawara Y; Nakata M; Konishi T; Nagawa H; Makuuchi M
World J Gastroenterol; 2006 Jan; 12(1):54-9. PubMed ID: 16440417
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of MUC1 mucin peptide core and the Thomsen-Friedenreich antigen in colorectal neoplasms.
Baldus SE; Hanisch FG; Kotlarek GM; Zirbes TK; Thiele J; Isenberg J; Karsten UR; Devine PL; Dienes HP
Cancer; 1998 Mar; 82(6):1019-27. PubMed ID: 9506345
[TBL] [Abstract][Full Text] [Related]
11. Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
Kawamoto T; Shoda J; Irimura T; Miyahara N; Furukawa M; Ueda T; Asano T; Kano M; Koike N; Fukao K; Tanaka N; Todoroki T
Clin Cancer Res; 2001 May; 7(5):1333-42. PubMed ID: 11350903
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
13. Expression of MUC1 and MUC2 mucins by human tumor cell lines.
Devine PL; Birrell GW; Whitehead RH; Harada H; Xing PX; McKenzie IF
Tumour Biol; 1992; 13(5-6):268-77. PubMed ID: 1283926
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence.
Baldus SE; Hanisch FG; Pütz C; Flucke U; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP
Histol Histopathol; 2002 Jan; 17(1):191-8. PubMed ID: 11813869
[TBL] [Abstract][Full Text] [Related]
15. Mucins secreted by cell lines derived from colorectal mucinous carcinoma and adenocarcinoma.
Cho M; Dahiya R; Choi SR; Siddiki B; Yeh MM; Sleisenger MH; Kim YS
Eur J Cancer; 1997 May; 33(6):931-41. PubMed ID: 9291818
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of MUC1 epithelial mucin expression in breast cancer.
McGuckin MA; Walsh MD; Hohn BG; Ward BG; Wright RG
Hum Pathol; 1995 Apr; 26(4):432-9. PubMed ID: 7705823
[TBL] [Abstract][Full Text] [Related]
17. Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas.
Feng H; Ghazizadeh M; Konishi H; Araki T
Jpn J Clin Oncol; 2002 Dec; 32(12):525-9. PubMed ID: 12578901
[TBL] [Abstract][Full Text] [Related]
18. Mucins (MUC1 and MUC3) of gastrointestinal and breast epithelia reveal different and heterogeneous tumor-associated aberrations in glycosylation.
Cao Y; Blohm D; Ghadimi BM; Stosiek P; Xing PX; Karsten U
J Histochem Cytochem; 1997 Nov; 45(11):1547-57. PubMed ID: 9358856
[TBL] [Abstract][Full Text] [Related]
19. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.
Hiraga Y; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N
Oncology; 1998; 55(4):307-19. PubMed ID: 9663420
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice.
Peat N; Gendler SJ; Lalani N; Duhig T; Taylor-Papadimitriou J
Cancer Res; 1992 Apr; 52(7):1954-60. PubMed ID: 1372533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
